CIK 0001682852
- Large accelerated filer
Moderna, Inc.
Sign in to watch- Ticker
- MRNA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813467528
- Phone
- +1 617-714-6500
- Business address
- 325 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- Moderna Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $50,775,837
- in 5 filings, $50.8M under 10b5-1 plans
Net −$50,775,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-23 | Bancel Stephane Chief Executive Officer | Sale | −6,138 | $147.71 | $907K | 5,445,808 |
| 2023-03-23 | Bancel Stephane Chief Executive Officer | Sale | −18,458 | $148.62 | $2.7M | 5,427,350 |
| 2023-03-23 | Bancel Stephane Chief Executive Officer | Sale | −5,906 | $149.61 | $884K | 5,421,444 |
| 2023-03-23 | Bancel Stephane Chief Executive Officer | Sale | −7,243 | $150.66 | $1.1M | 5,414,201 |
| 2023-03-23 | Bancel Stephane Chief Executive Officer | Sale | −996 | $151.53 | $151K | 5,413,205 |
| 2023-03-23 | Bancel Stephane Chief Executive Officer | Sale | −1,259 | $152.55 | $192K | 5,411,946 |
| 2023-03-23 | Bancel Stephane Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) | −40,000 | 1,067,155 | ||
| 2023-03-22 | Bancel Stephane Chief Executive Officer | Exercise or conversion | +40,000 | $0.99 | $40K | 5,451,946 |
| 2023-03-22 | Bancel Stephane Chief Executive Officer | Sale | −3,879 | $149.13 | $578K | 5,448,067 |
| 2023-03-22 | Bancel Stephane Chief Executive Officer | Sale | −18,321 | $149.84 | $2.7M | 5,429,746 |
| 2023-03-22 | Bancel Stephane Chief Executive Officer | Sale | −14,962 | $150.76 | $2.3M | 5,414,784 |
| 2023-03-22 | Bancel Stephane Chief Executive Officer | Sale | −2,838 | $151.67 | $430K | 5,411,946 |
| 2023-03-22 | Bancel Stephane Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) | −40,000 | 1,107,155 | ||
| 2023-03-16 | Bancel Stephane Chief Executive Officer | Exercise or conversion | +40,000 | $0.99 | $40K | 5,451,946 |
| 2023-03-16 | Bancel Stephane Chief Executive Officer | Sale | −4,200 | $148.63 | $624K | 5,447,746 |
| 2023-03-16 | Bancel Stephane Chief Executive Officer | Sale | −7,500 | $149.81 | $1.1M | 5,440,246 |
| 2023-03-16 | Bancel Stephane Chief Executive Officer | Sale | −7,600 | $150.39 | $1.1M | 5,432,646 |
| 2023-03-16 | Bancel Stephane Chief Executive Officer | Sale | −17,032 | $151.75 | $2.6M | 5,415,614 |
| 2023-03-16 | Bancel Stephane Chief Executive Officer | Sale | −3,668 | $152.49 | $559K | 5,411,946 |
| 2023-03-16 | Bancel Stephane Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) | −40,000 | 1,147,155 |
Page 52 of 66 · 1,314 trades